Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Clinical exome sequencing is frequently used to identify gene-disrupting variants in individuals with neurodevelopmental disorders. While splice-disrupting variants are known to contribute to these disorders, clinical interpretation of cryptic splice variants outside of the canonical splice site has been challenging. Here, we discuss papers that improve such detection.

More information Original publication

DOI

10.1186/s13073-020-00737-2

Type

Journal article

Publication Date

2020-04-24T00:00:00+00:00

Volume

12

Keywords

Antisense oligonucleotide, Autism spectrum disorder, Canonical splice site, Clinical exome sequencing, Cryptic splice site, Developmental delay, Gene splicing, Isoform, Polypyrimidine tract, SpliceAI, Humans, Neurodevelopmental Disorders, RNA Splicing